ImportantClick here to register for this event
This activity will provide improved understanding for physicians and laboratory workers by increasing knowledge related to the monitoring of various forms of the anticoagulant heparin. Emphasis will be placed on the role of the chromogenic anti-Xa assay as a measure of heparin activity. Clinical scenarios and outcomes studies will be discussed.
This activity is intended for health care professionals including pathologists, pharmacists and medical technologists who have a clinical interest in monitoring anticoagulants in the clinical setting.
Upon completion of this activity, participants should be able to:
1. Describe the biochemical nature of heparin including low molecular weight heparin (LMWH) and ultra-low molecular weight synthetic forms such as fondaparinux.
2. Review the anticoagulant mechanism of action of these various forms of heparin.
3. Compare the activated PTT and the anti-Xa assay as a means of monitoring heparin.
4. Explain the role of ATIII supplementation in the anti-Xa assay and the consequences thereof.
5. Discuss the clinical consequences of anti-Xa monitoring in the context of clinical scenarios.
Neil S. Harris, MBChB, MD
Educational Program Agenda
- 50 minutes: Course Instructive Materials
Disclosure of Conflicts of Interests
Global Education Group requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME accredited activity:
Planners and Managers
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse / life partner have with commercial interests related to the content of this P.A.C.E. accredited activity:
The planners and managers reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this ACPE activity:
Pharmacist Accreditation Statement
Credit Designation - Pharmacists
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-13-023-H01-P)
This is a Knowledge based activity.
ACPE Release and Expiration
Release Date: May 20, 2013
Global Education Group
For information about the physician accreditation of this activity, please contact Global Education Group at (303) 395-1782, or firstname.lastname@example.org.
Credit Designation - Lab Professional, P.A.C.E.®
The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.0 contact hours of credit.
Canadian Laboratory Professionals
How to Obtain P.A.C.E.® Credit
Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed between May 20, 2013 and May 20, 2015
Participation in this activity should be completed in approximately 1.0 hour. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:
Should you have any P.A.C.E.® questions regarding this activity, please contact:
*This program is approved for continuing education for ASCP BOC and all state Licensing bodies including CA and FL.
P.A.C.E.® Release And Expiration
Release Date: May 20, 2013
There is no fee for this educational activity.
Disclosure of Unlabeled Use/Investigational Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Dane Garvin Ltd. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Policy on Privacy and Confidentiality
Global Education Group (Global) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global Education Group and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
Global Education Group and Dane Garvin, Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
The American Society for Clinical Laboratory Science maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
This program has been made available online:
"Monitoring Heparin in the Clinical Laboratory"
Commercial Support Statement
This activity is supported by an educational grant from Diagnostica Stago.
Copyright © 2013 Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation use granted to Global Education Group (Global) and American Society for Clinical Laboratory Science (ASCLS).